
### [MONDO:0000649](http://purl.obolibrary.org/obo/MONDO_0000649)
**Label:** sensory system cancer

**Subclasses:** [MONDO:0008380](http://purl.obolibrary.org/obo/MONDO_0008380) (retinoblastoma), [MONDO:0019317](http://purl.obolibrary.org/obo/MONDO_0019317) (follicular atrophoderma-basal cell carcinoma), [MONDO:0015633](http://purl.obolibrary.org/obo/MONDO_0015633) (Bazex syndrome), [MONDO:0003927](http://purl.obolibrary.org/obo/MONDO_0003927) (posterior uveal melanoma), [MONDO:0001748](http://purl.obolibrary.org/obo/MONDO_0001748) (maxillary sinus cancer), [MONDO:0003802](http://purl.obolibrary.org/obo/MONDO_0003802) (cornea cancer), [MONDO:0002831](http://purl.obolibrary.org/obo/MONDO_0002831) (non-keratinizing sinonasal squamous cell carcinoma), [MONDO:0001743](http://purl.obolibrary.org/obo/MONDO_0001743) (paranasal sinus lymphoma), [MONDO:0004338](http://purl.obolibrary.org/obo/MONDO_0004338) (retinal cell cancer), [MONDO:0007966](http://purl.obolibrary.org/obo/MONDO_0007966) (susceptibility to uveal melanoma), [MONDO:0001740](http://purl.obolibrary.org/obo/MONDO_0001740) (cornea squamous cell carcinoma), [MONDO:0002432](http://purl.obolibrary.org/obo/MONDO_0002432) (malignant neoplasm of acoustic nerve), [MONDO:0001580](http://purl.obolibrary.org/obo/MONDO_0001580) (lacrimal duct cancer), [MONDO:0003880](http://purl.obolibrary.org/obo/MONDO_0003880) (ceruminous carcinoma), [MONDO:0006352](http://purl.obolibrary.org/obo/MONDO_0006352) (paranasal sinus adenoid cystic carcinoma), [MONDO:0001756](http://purl.obolibrary.org/obo/MONDO_0001756) (frontal sinus cancer), [MONDO:0021588](http://purl.obolibrary.org/obo/MONDO_0021588) (eyelid sebaceous gland carcinoma), [MONDO:0002969](http://purl.obolibrary.org/obo/MONDO_0002969) (ciliary body cancer), [MONDO:0001758](http://purl.obolibrary.org/obo/MONDO_0001758) (paranasal sinus sarcoma), [MONDO:0001995](http://purl.obolibrary.org/obo/MONDO_0001995) (sphenoid sinus squamous cell carcinoma), [MONDO:0003932](http://purl.obolibrary.org/obo/MONDO_0003932) (childhood optic nerve glioma), [MONDO:0001994](http://purl.obolibrary.org/obo/MONDO_0001994) (sphenoidal sinus cancer), [MONDO:0004349](http://purl.obolibrary.org/obo/MONDO_0004349) (retina lymphoma), [MONDO:0003931](http://purl.obolibrary.org/obo/MONDO_0003931) (childhood optic tract astrocytoma), [MONDO:0000380](http://purl.obolibrary.org/obo/MONDO_0000380) (paranasal sinus cancer), [MONDO:0004188](http://purl.obolibrary.org/obo/MONDO_0004188) (iris spindle cell melanoma), [MONDO:0006486](http://purl.obolibrary.org/obo/MONDO_0006486) (uveal melanoma), [MONDO:0004065](http://purl.obolibrary.org/obo/MONDO_0004065) (intermediate cell type choroid melanoma), [MONDO:0004066](http://purl.obolibrary.org/obo/MONDO_0004066) (intermediate cell type ciliary body melanoma), [MONDO:0004063](http://purl.obolibrary.org/obo/MONDO_0004063) (intermediate cell type iris melanoma), [MONDO:0003492](http://purl.obolibrary.org/obo/MONDO_0003492) (lacrimal gland squamous cell carcinoma), [MONDO:0004064](http://purl.obolibrary.org/obo/MONDO_0004064) (iris melanoma), [MONDO:0004062](http://purl.obolibrary.org/obo/MONDO_0004062) (intermediate cell type uveal melanoma), [MONDO:0003092](http://purl.obolibrary.org/obo/MONDO_0003092) (lacrimal gland mucoepidermoid carcinoma), [MONDO:0002659](http://purl.obolibrary.org/obo/MONDO_0002659) (uveal cancer), [MONDO:0002658](http://purl.obolibrary.org/obo/MONDO_0002658) (iris cancer), [MONDO:0002416](http://purl.obolibrary.org/obo/MONDO_0002416) (ethmoid sinus squamous cell carcinoma), [MONDO:0002418](http://purl.obolibrary.org/obo/MONDO_0002418) (ethmoid sinus adenocarcinoma), [MONDO:0003745](http://purl.obolibrary.org/obo/MONDO_0003745) (choroid spindle cell melanoma), [MONDO:0018161](http://purl.obolibrary.org/obo/MONDO_0018161) (non-hereditary retinoblastoma), [MONDO:0003746](http://purl.obolibrary.org/obo/MONDO_0003746) (ciliary body spindle cell melanoma), [MONDO:0003501](http://purl.obolibrary.org/obo/MONDO_0003501) (external ear squamous cell carcinoma), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), [MONDO:0003744](http://purl.obolibrary.org/obo/MONDO_0003744) (spindle cell intraocular melanoma), [MONDO:0003189](http://purl.obolibrary.org/obo/MONDO_0003189) (middle ear adenocarcinoma), [MONDO:0003984](http://purl.obolibrary.org/obo/MONDO_0003984) (internal auditory canal lipoma), [MONDO:0004556](http://purl.obolibrary.org/obo/MONDO_0004556) (carcinoma arising in nasal papillomatosis), [MONDO:0006059](http://purl.obolibrary.org/obo/MONDO_0006059) (nasal cavity squamous cell carcinoma), [MONDO:0004034](http://purl.obolibrary.org/obo/MONDO_0004034) (eye lymphoma), [MONDO:0002096](http://purl.obolibrary.org/obo/MONDO_0002096) (malignant conjunctival melanoma), [MONDO:0004550](http://purl.obolibrary.org/obo/MONDO_0004550) (malignant cornea melanoma), [MONDO:0006297](http://purl.obolibrary.org/obo/MONDO_0006297) (maxillary sinus adenoid cystic carcinoma), [MONDO:0004394](http://purl.obolibrary.org/obo/MONDO_0004394) (maxillary sinus squamous cell carcinoma), [MONDO:0006173](http://purl.obolibrary.org/obo/MONDO_0006173) (conjunctival squamous cell carcinoma), [MONDO:0000928](http://purl.obolibrary.org/obo/MONDO_0000928) (eyelid melanoma), [MONDO:0002944](http://purl.obolibrary.org/obo/MONDO_0002944) (external ear carcinoma), [MONDO:0003912](http://purl.obolibrary.org/obo/MONDO_0003912) (malignant ciliary body melanoma), [MONDO:0003913](http://purl.obolibrary.org/obo/MONDO_0003913) (choroid mixed cell melanoma), [MONDO:0004328](http://purl.obolibrary.org/obo/MONDO_0004328) (maxillary sinus adenocarcinoma), [MONDO:0003910](http://purl.obolibrary.org/obo/MONDO_0003910) (mixed cell uveal melanoma), [MONDO:0003878](http://purl.obolibrary.org/obo/MONDO_0003878) (malignant choroid melanoma), [MONDO:0003911](http://purl.obolibrary.org/obo/MONDO_0003911) (ciliary body mixed cell melanoma), [MONDO:0002943](http://purl.obolibrary.org/obo/MONDO_0002943) (external ear basal cell carcinoma), [MONDO:0003876](http://purl.obolibrary.org/obo/MONDO_0003876) (eyelid carcinoma), [MONDO:0003234](http://purl.obolibrary.org/obo/MONDO_0003234) (optic nerve astrocytoma), [MONDO:0002301](http://purl.obolibrary.org/obo/MONDO_0002301) (frontal sinus squamous cell carcinoma), [MONDO:0003235](http://purl.obolibrary.org/obo/MONDO_0003235) (optic nerve glioma), [MONDO:0004045](http://purl.obolibrary.org/obo/MONDO_0004045) (pediatric intraocular retinoblastoma), [MONDO:0003076](http://purl.obolibrary.org/obo/MONDO_0003076) (unilateral retinoblastoma), [MONDO:0003075](http://purl.obolibrary.org/obo/MONDO_0003075) (bilateral retinoblastoma), [MONDO:0003078](http://purl.obolibrary.org/obo/MONDO_0003078) (extraocular retinoblastoma), [MONDO:0003077](http://purl.obolibrary.org/obo/MONDO_0003077) (intraocular retinoblastoma), [MONDO:0004561](http://purl.obolibrary.org/obo/MONDO_0004561) (retinal melanoma), [MONDO:0003072](http://purl.obolibrary.org/obo/MONDO_0003072) (retinal cancer), [MONDO:0003074](http://purl.obolibrary.org/obo/MONDO_0003074) (familial retinoblastoma), [MONDO:0003073](http://purl.obolibrary.org/obo/MONDO_0003073) (trilateral retinoblastoma), [MONDO:0003190](http://purl.obolibrary.org/obo/MONDO_0003190) (middle ear carcinoma), [MONDO:0021313](http://purl.obolibrary.org/obo/MONDO_0021313) (eyelid cancer), [MONDO:0002236](http://purl.obolibrary.org/obo/MONDO_0002236) (ocular cancer), [MONDO:0004659](http://purl.obolibrary.org/obo/MONDO_0004659) (eye carcinoma in situ), [MONDO:0003722](http://purl.obolibrary.org/obo/MONDO_0003722) (internal auditory canal meningioma), [MONDO:0002475](http://purl.obolibrary.org/obo/MONDO_0002475) (lacrimal gland adenocarcinoma), [MONDO:0004532](http://purl.obolibrary.org/obo/MONDO_0004532) (auditory system cancer), [MONDO:0017206](http://purl.obolibrary.org/obo/MONDO_0017206) (primary intraocular lymphoma), [MONDO:0017205](http://purl.obolibrary.org/obo/MONDO_0017205) (primary oculocerebral lymphoma), [MONDO:0000500](http://purl.obolibrary.org/obo/MONDO_0000500) (tongue squamous cell carcinoma), [MONDO:0006327](http://purl.obolibrary.org/obo/MONDO_0006327) (ocular sebaceous carcinoma), [MONDO:0003212](http://purl.obolibrary.org/obo/MONDO_0003212) (nasal cavity carcinoma), [MONDO:0006326](http://purl.obolibrary.org/obo/MONDO_0006326) (ocular melanoma with extraocular extension), [MONDO:0003211](http://purl.obolibrary.org/obo/MONDO_0003211) (nasal cavity adenocarcinoma), [MONDO:0006325](http://purl.obolibrary.org/obo/MONDO_0006325) (ocular melanoma), [MONDO:0003574](http://purl.obolibrary.org/obo/MONDO_0003574) (external ear cancer), [MONDO:0003454](http://purl.obolibrary.org/obo/MONDO_0003454) (conjunctival cancer), [MONDO:0006201](http://purl.obolibrary.org/obo/MONDO_0006201) (ethmoid sinus adenoid cystic carcinoma), [MONDO:0020175](http://purl.obolibrary.org/obo/MONDO_0020175) (malignant tumor of palpebral epidermis), [MONDO:0006200](http://purl.obolibrary.org/obo/MONDO_0006200) (epithelioid cell uveal melanoma), [MONDO:0010535](http://purl.obolibrary.org/obo/MONDO_0010535) (Bazex-DuprC)-Christol syndrome), [MONDO:0011695](http://purl.obolibrary.org/obo/MONDO_0011695) (melanoma, uveal, susceptibility to, 1), [MONDO:0001129](http://purl.obolibrary.org/obo/MONDO_0001129) (nasal cavity olfactory neuroblastoma), [MONDO:0001763](http://purl.obolibrary.org/obo/MONDO_0001763) (ethmoid sinus cancer), [MONDO:0001128](http://purl.obolibrary.org/obo/MONDO_0001128) (nasal cavity cancer), [MONDO:0004631](http://purl.obolibrary.org/obo/MONDO_0004631) (tongue cancer), [MONDO:0003784](http://purl.obolibrary.org/obo/MONDO_0003784) (nasal cavity carcinoma in situ), [MONDO:0004351](http://purl.obolibrary.org/obo/MONDO_0004351) (intraocular lymphoma), [MONDO:0007187](http://purl.obolibrary.org/obo/MONDO_0007187) (nevoid basal cell carcinoma syndrome), [MONDO:0004350](http://purl.obolibrary.org/obo/MONDO_0004350) (pediatric extraocular retinoblastoma), [MONDO:0011696](http://purl.obolibrary.org/obo/MONDO_0011696) (melanoma, uveal, susceptibility to, 2), [MONDO:0002469](http://purl.obolibrary.org/obo/MONDO_0002469) (lacrimal gland carcinoma ex pleomorphic adenoma), [MONDO:0003278](http://purl.obolibrary.org/obo/MONDO_0003278) (inner ear cancer), [MONDO:0002464](http://purl.obolibrary.org/obo/MONDO_0002464) (lacrimal gland cancer), [MONDO:0002463](http://purl.obolibrary.org/obo/MONDO_0002463) (lacrimal gland carcinoma), [MONDO:0003277](http://purl.obolibrary.org/obo/MONDO_0003277) (malignant ear neoplasm), [MONDO:0006700](http://purl.obolibrary.org/obo/MONDO_0006700) (choroid cancer), [MONDO:0006303](http://purl.obolibrary.org/obo/MONDO_0006303) (middle ear squamous cell carcinoma), [MONDO:0002466](http://purl.obolibrary.org/obo/MONDO_0002466) (eye carcinoma), [MONDO:0004364](http://purl.obolibrary.org/obo/MONDO_0004364) (choroid necrotic melanoma), [MONDO:0002460](http://purl.obolibrary.org/obo/MONDO_0002460) (lacrimal system cancer), [MONDO:0004365](http://purl.obolibrary.org/obo/MONDO_0004365) (necrotic uveal melanoma), [MONDO:0001130](http://purl.obolibrary.org/obo/MONDO_0001130) (nasal cavity lymphoma), [MONDO:0003275](http://purl.obolibrary.org/obo/MONDO_0003275) (middle ear cancer), [MONDO:0004085](http://purl.obolibrary.org/obo/MONDO_0004085) (choroid epithelioid cell melanoma), [MONDO:0004086](http://purl.obolibrary.org/obo/MONDO_0004086) (ciliary body epithelioid cell melanoma), [MONDO:0006262](http://purl.obolibrary.org/obo/MONDO_0006262) (lacrimal gland adenoid cystic carcinoma), 

**Mapped go classes:** [GO:0045606](http://purl.obolibrary.org/obo/GO_0045606) (positive regulation of epidermal cell differentiation), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0048635](http://purl.obolibrary.org/obo/GO_0048635) (negative regulation of muscle organ development), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0021513](http://purl.obolibrary.org/obo/GO_0021513) (spinal cord dorsal/ventral patterning), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:1901621](http://purl.obolibrary.org/obo/GO_1901621) (negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0002088](http://purl.obolibrary.org/obo/GO_0002088) (lens development in camera-type eye), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0008158](http://purl.obolibrary.org/obo/GO_0008158) (hedgehog receptor activity), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005119](http://purl.obolibrary.org/obo/GO_0005119) (smoothened binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0035904](http://purl.obolibrary.org/obo/GO_0035904) (aorta development), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0035301](http://purl.obolibrary.org/obo/GO_0035301) (Hedgehog signaling complex), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0021775](http://purl.obolibrary.org/obo/GO_0021775) (smoothened signaling pathway involved in ventral spinal cord interneuron specification), [GO:0021776](http://purl.obolibrary.org/obo/GO_0021776) (smoothened signaling pathway involved in spinal cord motor neuron cell fate specification), [GO:0042994](http://purl.obolibrary.org/obo/GO_0042994) (cytoplasmic sequestering of transcription factor), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0097108](http://purl.obolibrary.org/obo/GO_0097108) (hedgehog family protein binding), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:2000059](http://purl.obolibrary.org/obo/GO_2000059) (negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0003281](http://purl.obolibrary.org/obo/GO_0003281) (ventricular septum development), [GO:0060976](http://purl.obolibrary.org/obo/GO_0060976) (coronary vasculature development), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0010002](http://purl.obolibrary.org/obo/GO_0010002) (cardioblast differentiation), 

**Class expressions from DL-Learner:**

- [GO:0021910](http://purl.obolibrary.org/obo/GO_0021910) (smoothened signaling pathway involved in ventral spinal cord patterning) 54.35%
- Thing 53.07%
- [GO:1901621](http://purl.obolibrary.org/obo/GO_1901621) (negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning) 52.17%
- [GO:0060976](http://purl.obolibrary.org/obo/GO_0060976) (coronary vasculature development) 52.17%
- [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye) 52.17%
- [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye) 52.17%
- [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development) 52.17%
- [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle) 52.17%
- [GO:0042303](http://purl.obolibrary.org/obo/GO_0042303) (molting cycle) 52.17%
- [GO:0035301](http://purl.obolibrary.org/obo/GO_0035301) (Hedgehog signaling complex) 52.17%
- [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex) 52.17%
- [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance) 52.17%
- [GO:0021776](http://purl.obolibrary.org/obo/GO_0021776) (smoothened signaling pathway involved in spinal cord motor neuron cell fate specification) 52.17%
- [GO:0021775](http://purl.obolibrary.org/obo/GO_0021775) (smoothened signaling pathway involved in ventral spinal cord interneuron specification) 52.17%
- [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development) 52.17%


